Effectiveness of Sacha Inchi Supplementation on Postprandial Inflammation
ESISOPI
Effect of Supplementation of a High-fat Meal With Sacha Inchi Oil on Postprandial Metabolic and Inflammatory Responses in Adults With Low Physical Activity and Without Abdominal Obesity
1 other identifier
interventional
42
1 country
1
Brief Summary
The postprandial state increases triglyceride-rich lipoproteins and lipopolysaccharide (LPS) levels, promoting cellular lipids accumulation, insulin resistance, increased inflammatory markers and the formation of foam cells, a situation that can have different effects depending the type of dietary fat and presence of metabolic conditions such as abdominal obesity and insulin resistance. Given that the diet of the Colombian population is rich in saturated fats, and taking into consideration the general resistance to complex dietary changes, the purpose of this study is to evaluate whether Sacha Inchi oil supplementation of a high-fat meal is effective in reducing levels of biochemical markers of cardiovascular risk in adults with and without abdominal obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 11, 2016
CompletedFirst Posted
Study publicly available on registry
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedApril 23, 2019
April 1, 2019
6 months
August 11, 2016
April 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of the different meal combinations on change from baseline plasma triglycerides (in mg/dL) at 1 and 4 hours after breakfast
0, 1 and 4 hours after breakfast
Secondary Outcomes (6)
Effect of the different meal combinations on change from baseline plasma Cholesterol (in mg/dL) at 1 and 4 hours after breakfast
0, 1 and 4 hours after breakfast
Effect of the different meal combinations on change from baseline plasma High density lipoprotein cholesterol (HDL-Cholesterol , in mg/dL) at 1 and 4 hours after breakfast
0, 1 and 4 hours after breakfast
Effect of the different meal combinations on change from baseline plasma Glucose (in mg/dL) at 1 and 4 hours
0, 1 and 4 hours after breakfast
Effect of the different meal combinations on change from baseline plasma insulin (in uIU/mL) at 1 and 4 hours
0, 1 and 4 hours after breakfast
Effect of the different meal combinations on change from baseline plasma Homeostatic model assessment (HOMA index) (in uIU/mL) at 1 and 4 hours
0, 1 and 4 hours after breakfast
- +1 more secondary outcomes
Study Arms (2)
High fat meal with Sacha Inchi
EXPERIMENTALParticipants will receive 100 g of bread with 70 g of butter (high saturated fat meal) added with 15ml of Sacha Inchi oil and 125ml of coffee with 10g of sugar
unsupplemented group
PLACEBO COMPARATORParticipants will receive 100 g of bread with 70 g of butter (high saturated fat meal) and 125ml of coffee with 10g of sugar
Interventions
Participants will receive 100 g of bread with 70 g of butter (high saturated fat meal) added with 15ml of Sacha Inchi oil and 125ml of coffee with 10g of sugar
Participants will receive 100 g of bread with 70 g of butter (high saturated fat meal) and 125ml of coffee with 10g of sugar
Eligibility Criteria
You may qualify if:
- Men aged between 27 and 59 years.
- Give voluntary, signed informed consent.
- Group A: Be non-obese as defined as Waist circumference \< 92 cm (Gallo, 2003)
- Group B: Be obese as defined as Waist circumference \> 92 cm
- Physical inactivity (Adults aged 18-64 who do less than 150 minutes of moderate
- intensity aerobic physical activity throughout the week or less than 75 minutes of
- vigorous-intensity aerobic physical activity throughout the week or an equivalent
- combination of moderate- and vigorous-intensity activity).
You may not qualify if:
- Individuals with known gastrointestinal, renal or cardiovascular diseases, diabetes mellitus, fat intolerance, or those taking medications known to affect lipid metabolism or fat absorption.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Icesilead
- Universidad de San Buenaventuracollaborator
Study Sites (1)
University of San Buenaventura
Cartagena, Departamento de Bolívar, 130010, Colombia
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Isabella Echeverri, Doctor
Icesi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2016
First Posted
September 1, 2016
Study Start
March 1, 2016
Primary Completion
September 1, 2016
Study Completion
November 1, 2017
Last Updated
April 23, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will share